Knowledge Library

Introducing High-Quality and Cost-Effective R&D and GMP Plasmid DNA

WuXi Advanced Therapies Inc. (WuXi ATU) today announced the expansion of its Cell & Gene Therapy Platforms with capabilities to provide high-quality and cost-effective supplies of R&D and GMP Plasmid for use in a wide variety of R&D, clinical, and  commercial bioprocessing applications, with an integrated platform of capabilities that allows for a seamless single-source approach …Read More >

Resource Type: White Paper
Resource Topic: Clinical & Commercial Manufacturing

VIEW